Nomination committee appointed As per specifications set at Meda's 2009 annual general meeting, a nomination committee has been appointed. It consists of: Karl-Magnus Sjölin, Committee Chairman, Stena Sessan Rederi AB Bert Åke Eriksson, Meda's board chairman, Stena Sessan Rederi AB Eva Halvarsson, the Second AP Fund Frank Larsson, Handelsbanken Fonder Peter Rudman, Nordea's funds Kerstin Stenberg, Swedbank Robur funds If questions, please contact: Karl-Magnus Sjölin, Committee Chairman, ph. +46 31-774 35 35 Anders Larnholt, Vice President Corporate Development & IR, ph: +46 709-458 878 MEDA AB (publ) is a leading international specialty pharma company. Meda's products are sold in 120 countries worldwide and the company is represented by its own organizations in more than 40 countries. The Meda share is listed under Large Cap on the Nasdaq OMX Nordic Stock Exchange in Stockholm. Find out more, visit www.meda.se.
Nomination committee appointed
| Source: Meda AB
Attachments
